Recent reports indicate that the high expression of EZH2 in gliomas is attributed to HCMV infection, and successful induction of GBM was achieved in vitro models by transplanting HCMV-infected astrocytes (Guyon 2024). The gene discussed is EZH2; the disease is central nervous system cancer.